| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12:42 | Lion Rock Resources appoints Terry Lyons to board | ||
| 12:42 | PROG Holdings plans $100 million accelerated share buyback | ||
| 12:42 | Susquehanna cuts Enphase Energy stock price target on weak demand | ||
| 12:42 | Morgan Stanley raises Visa stock price target on stable earnings growth | ||
| 12:42 | Morgan Stanley raises Innio stock price target to $42 on strong results | ||
| 12:42 | Morgan Stanley raises PayPal stock price target to $46 on cost execution | ||
| 12:42 | Morgan Stanley lowers Seagate stock price target on weaker exabyte growth | ||
| 12:42 | Morgan Stanley cuts Boeing stock price target on cash flow delays | ||
| 12:42 | Morgan Stanley raises Coca-Cola stock price target on pricing power | ||
| 12:42 | Morgan Stanley cuts Enphase Energy stock price target on demand concerns | ||
| 12:42 | Morgan Stanley raises S&P Global stock price target on earnings beat | ||
| 12:42 | Oppenheimer maintains Perform rating on Intapp stock amid AI push | ||
| 12:30 | Quick Heal Q2 FY27 slides: profit returns as enterprise gains | ||
| 12:30 | Mapletree Logistics Q2 FY26/27 slides: stable DPU, leverage drops | ||
| 12:30 | mBank Q3 2026 slides: record profit as margin rebounds from rate cuts | ||
| 12:30 | Wells Fargo cuts Hubbell stock price target on margin pressures | ||
| 12:30 | Oppenheimer reiterates Outperform on UroGen Pharma stock at $60 | ||
| 12:30 | Needham initiates Clover Health stock with buy on cohort economics | ||
| 12:30 | Wells Fargo raises Johnson Controls stock price target on growth outlook | ||
| 12:30 | Needham initiates Alignment Healthcare stock rating at Hold | ||
| 12:30 | Needham raises SK Hynix stock price target to $235 on supply outlook | ||
| 12:18 | Nebras Energy Q3 2026 slides: profit surges 25% on JV gains | ||
| 12:18 | Inventus Mining reports final Phase 2 drill results from Pardo | ||
| 12:18 | Abasca completes summer drill program at Key Lake South project | ||
| 12:18 | United Therapeutics gets FDA nod for PAH combination therapy trial |